Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque
2010

Rac1's Role in Platelet Aggregation and Secretion

Sample size: 7 publication Evidence: high

Author Information

Author(s): Dwivedi Suman, Pandey Dharmendra, Khandoga Anna L, Brandl Richard, Siess Wolfgang

Primary Institution: Institute for Prevention of Cardiovascular Diseases, University of Munich, Munich, Germany

Hypothesis

Does the Rac1-specific inhibitor NSC23766 inhibit platelet secretion and aggregation in blood?

Conclusion

Inhibiting Rac1 with NSC23766 significantly reduces platelet aggregation and secretion in response to various stimuli, including atherosclerotic plaque.

Supporting Evidence

  • NSC23766 inhibited TRAP-, collagen-, and plaque-induced platelet aggregation by up to 95%.
  • Platelet ATP-secretion was reduced by 73% and 85% after TRAP and collagen stimulation, respectively.
  • NSC23766 completely inhibited P-selectin expression in stimulated platelets.
  • Platelet adhesion to atherosclerotic plaque was reduced by 72% under flow conditions.

Takeaway

This study shows that a special drug can stop blood cells called platelets from clumping together when they are activated by certain signals, which could help prevent blood clots.

Methodology

The study measured platelet aggregation and ATP-secretion in blood and platelet-rich plasma using multiple electrode aggregometry and flow cytometry.

Participant Demographics

Healthy volunteers provided blood samples.

Statistical Information

P-Value

p<0.003; p<0.04; p<0.03; p<0.004; p<0.002

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1479-5876-8-128

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication